Cargando…

The High Cost of Diabetes Drugs: Disparate Impact on the Most Vulnerable Patients

Detalles Bibliográficos
Autor principal: Taylor, Simeon I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8051261/
https://www.ncbi.nlm.nih.gov/pubmed/32958616
http://dx.doi.org/10.2337/dci20-0039
_version_ 1783679717358960640
author Taylor, Simeon I.
author_facet Taylor, Simeon I.
author_sort Taylor, Simeon I.
collection PubMed
description
format Online
Article
Text
id pubmed-8051261
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-80512612021-10-01 The High Cost of Diabetes Drugs: Disparate Impact on the Most Vulnerable Patients Taylor, Simeon I. Diabetes Care Commentaries American Diabetes Association 2020-10 2020-09-11 /pmc/articles/PMC8051261/ /pubmed/32958616 http://dx.doi.org/10.2337/dci20-0039 Text en © 2020 by the American Diabetes Association https://www.diabetesjournals.org/content/licenseReaders may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at https://www.diabetesjournals.org/content/license.
spellingShingle Commentaries
Taylor, Simeon I.
The High Cost of Diabetes Drugs: Disparate Impact on the Most Vulnerable Patients
title The High Cost of Diabetes Drugs: Disparate Impact on the Most Vulnerable Patients
title_full The High Cost of Diabetes Drugs: Disparate Impact on the Most Vulnerable Patients
title_fullStr The High Cost of Diabetes Drugs: Disparate Impact on the Most Vulnerable Patients
title_full_unstemmed The High Cost of Diabetes Drugs: Disparate Impact on the Most Vulnerable Patients
title_short The High Cost of Diabetes Drugs: Disparate Impact on the Most Vulnerable Patients
title_sort high cost of diabetes drugs: disparate impact on the most vulnerable patients
topic Commentaries
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8051261/
https://www.ncbi.nlm.nih.gov/pubmed/32958616
http://dx.doi.org/10.2337/dci20-0039
work_keys_str_mv AT taylorsimeoni thehighcostofdiabetesdrugsdisparateimpactonthemostvulnerablepatients
AT taylorsimeoni highcostofdiabetesdrugsdisparateimpactonthemostvulnerablepatients